Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

308.70USD
26 May 2017
Change (% chg)

$0.11 (+0.04%)
Prev Close
$308.59
Open
$308.40
Day's High
$308.94
Day's Low
$307.95
Volume
451,830
Avg. Vol
858,853
52-wk High
$309.16
52-wk Low
$203.63

DeFord, John 

Dr. John A. DeFord, Ph.D., is Senior Vice President-Science, Technology and Clinical Affairs of Company. Dr. DeFord joined Bard in 2004 as Vice President, Science & Technology after serving as Managing Director with Early Stage Partners, LLP (ESP), a venture capital fund, from 2002 until 2004. Before joining ESP he was President and CEO of Cook Incorporated, a privately-held medical device Company. He was promoted to Senior Vice President-Science, Technology & Clinical Affairs in 2007.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Timothy Ring

12,626,500

John Weiland

7,121,000

James Beasley

4,290,960

Timothy Collins

4,309,940

John Groetelaars

--

Christopher Holland

3,949,350
As Of  30 Dec 2016